ArticleHead & face medicine2021

A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis.

Giuseppina Campisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.